Christiane Drechsler
Overview
Explore the profile of Christiane Drechsler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
3219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
de Rooij E, Meuleman Y, De Fijter J, Jager K, Chesnaye N, Evans M, et al.
Clin J Am Soc Nephrol
. 2022 Nov;
17(12):1719-1729.
PMID: 36357126
Background And Objectives: For older patients with kidney failure, lowering symptom burden may be more important than prolonging life. Dialysis initiation may affect individual kidney failure-related symptoms differently, but the...
12.
Ramspek C, Boekee R, Evans M, Heimburger O, Snead C, Caskey F, et al.
Kidney Int Rep
. 2022 Oct;
7(10):2230-2241.
PMID: 36217520
Introduction: Predicting the timing and occurrence of kidney replacement therapy (KRT), cardiovascular events, and death among patients with advanced chronic kidney disease (CKD) is clinically useful and relevant. We aimed...
13.
Dai L, Massy Z, Stenvinkel P, Chesnaye N, Larabi I, Alvarez J, et al.
Am J Clin Nutr
. 2022 Sep;
116(6):1842-1851.
PMID: 36166845
Background: Trimethylamine N-oxide (TMAO), a metabolite from red meat and fish consumption, plays a role in promoting cardiovascular events. However, data regarding TMAO and its impact on clinical outcomes are...
14.
Hammer F, Genser B, Dieplinger B, Egger M, Muller T, Drechsler C, et al.
Clin Kidney J
. 2022 Sep;
15(10):1915-1923.
PMID: 36158148
Background: Soluble suppression of tumorigenesis-2 (sST2) is a strong prognostic biomarker of cardiovascular (CV) disease. End-stage kidney disease (ESKD) patients are at high risk of CV events and infections. Herein...
15.
de Rooij E, Meuleman Y, De Fijter J, le Cessie S, Jager K, Chesnaye N, et al.
Clin J Am Soc Nephrol
. 2022 Jul;
17(8):1159-1167.
PMID: 35902127
Background And Objectives: In older people with kidney failure, improving health-related quality of life is often more important than solely prolonging life. However, little is known about the effect of...
16.
Massy Z, Chesnaye N, Larabi I, Dekker F, Evans M, Caskey F, et al.
Clin Kidney J
. 2022 Apr;
15(4):798-807.
PMID: 35371454
Background: Patients with stage 4/5 chronic kidney disease (CKD) suffer from various symptoms. The retention of uremic solutes is thought to be associated with those symptoms. However, there are relatively...
17.
Gates E, Hole B, Hayward S, Chesnaye N, Meuleman Y, Dekker F, et al.
BMC Med Res Methodol
. 2022 Feb;
22(1):44.
PMID: 35148682
Background: Prospective cohort studies are challenging to deliver, with one of the main difficulties lying in retention of participants. The need to socially distance during the COVID-19 pandemic has added...
18.
Chesnaye N, Meuleman Y, de Rooij E, Hoogeveen E, Dekker F, Evans M, et al.
Clin J Am Soc Nephrol
. 2022 Jan;
17(2):205-214.
PMID: 35074845
Background And Objectives: The effect of sex on longitudinal health-related quality of life remains unknown in CKD. Here we assess differences in the sex-specific evolution of health-related quality of life...
19.
Kaesler N, Schreibing F, Speer T, de la Puente-Secades S, Rapp N, Drechsler C, et al.
Kidney Int
. 2021 Nov;
101(2):338-348.
PMID: 34774554
Chronic kidney disease (CKD) is accompanied with extensive cardiovascular calcification, in part correlating with functional vitamin K deficiency. Here, we sought to determine causes for vitamin K deficiency beyond reduced...
20.
Pfau A, Ermer T, Coca S, Tio M, Genser B, Reichel M, et al.
J Am Soc Nephrol
. 2021 Jul;
32(9):2375-2385.
PMID: 34281958
Background: The clinical significance of accumulating toxic terminal metabolites such as oxalate in patients with kidney failure is not well understood. Methods: To evaluate serum oxalate concentrations and risk of...